Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q4 2016 call → NOThe question asks whether management explains the company's business direction by narrating what its counterparties are themselves doing and scaling. Let me analyze the transcript carefully. Looking at the transcript, Paul Manning discusses several areas: 1. **Natural colors**: He discusses the shift from synthetic to natural colors, mentioning that "many of the world's largest food companies including some of the largest food retailers have announced their intentions to use natural colors in their products." He says "Some of these products have already hit the shelves and others will take several years to make the conversion to natural colors." He also says "We expect these conversions to take place gradually and consistently over the next few years, with more of the near term conversion activity coming from local and regional manufacturers or private label brands." 2. **Cosmetics**: He discusses strong demand for makeup, lipstick, and other personal care products, driven by "new product launches across a wide range of products due to changing consumer preferences." 3. **Flavors and fragrances**: He discusses the company's own restructuring, product mix shifts, and internal improvements. Now, let me evaluate against the three criteria: **(1) Management speaks about counterparties' business as though it were part of its own.** In the natural colors discussion, Paul Manning does describe what food companies are doing - they have "announced their intentions to use natural colors" and some products "have already hit the shelves." He describes the conversion activity as coming from "local and regional manufacturers or private label brands." This is describing counterparties' trajectories. However, is this a substantial part of the forward account? The natural colors discussion is one part of the call. The flavors and fragrances discussion is largely about the company's own restructuring, product mix, and internal optimization. The cosmetics discussion is about general demand trends and the company's own innovation program. **(2) The company is already inside that growth, not bidding for it.** For natural colors, the company is clearly already supplying - "Our natural color sales have been strong all year with double-digit sales growth in North America and Latin America." So the company is already inside this growth.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.